(2S,5S)-2-[3-(carbamoylamino)propyl]-5-[[2-[3-[3,5-di(prop-2-enoyl)-1,3,5-triazinan-1-yl]-3-oxopropyl]sulfanylacetyl]amino]-N-[4-(hydroxymethyl)phenyl]-6-methyl-4-oxoheptanamide;(2S,5S)-2-[3-(carbamoylamino)propyl]-N-[4-(hydroxymethyl)phenyl]-6-methyl-5-(methylamino)-4-oxoheptanamide;2-[3-[3,5-di(prop-2-enoyl)-1,3,5-triazinan-1-yl]-3-oxopropyl]sulfanylacetic acid
C67H98N14O17S2 — CID 159213046
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S,5S)-2-[3-(carbamoylamino)propyl]-5-[[2-[3-[3,5-di(prop-2-enoyl)-1,3,5-triazinan-1-yl]-3-oxopropyl]sulfanylacetyl]amino]-N-[4-(hydroxymethyl)phenyl]-6-methyl-4-oxoheptanamide;(2S,5S)-2-[3-(carbamoylamino)propyl]-N-[4-(hydroxymethyl)phenyl]-6-methyl-5-(methylamino)-4-oxoheptanamide;2-[3-[3,5-di(prop-2-enoyl)-1,3,5-triazinan-1-yl]-3-oxopropyl]sulfanylacetic acid
(2S,5S)-2-[3-(carbamoylamino)propyl]-5-[[2-[3-[3,5-di(prop-2-enoyl)-1,3,5-triazinan-1-yl]-3-oxopropyl]sulfanylacetyl]amino]-N-[4-(hydroxymethyl)phenyl]-6-methyl-4-oxoheptanamide;(2S,5S)-2-[3-(carbamoylamino)propyl]-N-[4-(hydroxymethyl)phenyl]-6-methyl-5-(methylamino)-4-oxoheptanamide;2-[3-[3,5-di(prop-2-enoyl)-1,3,5-triazinan-1-yl]-3-oxopropyl]sulfanylacetic acid (PubChem CID 159213046) has the molecular formula C67H98N14O17S2 and a molecular weight of 1435.74 g/mol. Its IUPAC name is (2S,5S)-2-[3-(carbamoylamino)propyl]-5-[[2-[3-[3,5-di(prop-2-enoyl)-1,3,5-triazinan-1-yl]-3-oxopropyl]sulfanylacetyl]amino]-N-[4-(hydroxymethyl)phenyl]-6-methyl-4-oxoheptanamide;(2S,5S)-2-[3-(carbamoylamino)propyl]-N-[4-(hydroxymethyl)phenyl]-6-methyl-5-(methylamino)-4-oxoheptanamide;2-[3-[3,5-di(prop-2-enoyl)-1,3,5-triazinan-1-yl]-3-oxopropyl]sulfanylacetic acid.
Molecular Properties
| Compound Name | (2S,5S)-2-[3-(carbamoylamino)propyl]-5-[[2-[3-[3,5-di(prop-2-enoyl)-1,3,5-triazinan-1-yl]-3-oxopropyl]sulfanylacetyl]amino]-N-[4-(hydroxymethyl)phenyl]-6-methyl-4-oxoheptanamide;(2S,5S)-2-[3-(carbamoylamino)propyl]-N-[4-(hydroxymethyl)phenyl]-6-methyl-5-(methylamino)-4-oxoheptanamide;2-[3-[3,5-di(prop-2-enoyl)-1,3,5-triazinan-1-yl]-3-oxopropyl]sulfanylacetic acid |
|---|---|
| PubChem CID | 159213046 |
| Molecular Formula | C67H98N14O17S2 |
| Molecular Weight | 1435.74 g/mol |
| Exact Mass | 1434.67 |
| IUPAC Name | (2S,5S)-2-[3-(carbamoylamino)propyl]-5-[[2-[3-[3,5-di(prop-2-enoyl)-1,3,5-triazinan-1-yl]-3-oxopropyl]sulfanylacetyl]amino]-N-[4-(hydroxymethyl)phenyl]-6-methyl-4-oxoheptanamide;(2S,5S)-2-[3-(carbamoylamino)propyl]-N-[4-(hydroxymethyl)phenyl]-6-methyl-5-(methylamino)-4-oxoheptanamide;2-[3-[3,5-di(prop-2-enoyl)-1,3,5-triazinan-1-yl]-3-oxopropyl]sulfanylacetic acid |
| SMILES | C=CC(=O)N1CN(C(=O)C=C)CN(C(=O)CCSCC(=O)N[C@H](C(=O)C[C@H](CCCNC(N)=O)C(=O)Nc2ccc(CO)cc2)C(C)C)C1.C=CC(=O)N1CN(C(=O)C=C)CN(C(=O)CCSCC(=O)O)C1.CN[C@H](C(=O)C[C@H](CCCNC(N)=O)C(=O)Nc1ccc(CO)cc1)C(C)C |
| InChI | InChI=1S/C33H47N7O8S.C20H32N4O4.C14H19N3O5S/c1-5-28(44)38-19-39(29(45)6-2)21-40(20-38)30(46)13-15-49-18-27(43)37-31(22(3)4)26(42)16-24(8-7-14-35-33(34)48)32(47)36-25-11-9-23(17-41)10-12-25;1-13(2)18(22-3)17(26)11-15(5-4-10-23-20(21)28)19(27)24-16-8-6-14(12-25)7-9-16;1-3-11(18)15-8-16(12(19)4-2)10-17(9-15)13(20)5-6-23-7-14(21)22/h5-6,9-12,22,24,31,41H,1-2,7-8,13-21H2,3-4H3,(H,36,47)(H,37,43)(H3,34,35,48);6-9,13,15,18,22,25H,4-5,10-12H2,1-3H3,(H,24,27)(H3,21,23,28);3-4H,1-2,5-10H2,(H,21,22)/t24-,31-;15-,18-;/m00./s1 |
| InChIKey | KQSUYELHLCZIPH-FYLVSFRGSA-N |
| XLogP | 2.47 |
| TPSA | 443.33 Ų |
| H-Bond Donors | 11 |
| H-Bond Acceptors | 19 |
| Rotatable Bonds | 38 |
| Heavy Atoms | 100 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1435.74 |
| LogP ≤ 5 | 2.47 |
| H-Bond Donors ≤ 5 | 11 |
| H-Bond Acceptors ≤ 10 | 19 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159213046 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.